Almenoff June Sherie 4
4 · Avalo Therapeutics, Inc. · Filed Dec 21, 2023
Insider Transaction Report
Form 4
Almenoff June Sherie
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-12-20+3,334→ 3,334 totalExercise: $0.04From: 2024-12-20Exp: 2033-12-20→ Common Stock (3,334 underlying)
Footnotes (1)
- [F1]The stock option will vest in full on December 20, 2024, subject to the Reporting Person's continued service on such vesting date.